{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T15:35:09Z","timestamp":1773070509249,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum M\u00fcnster"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Sarcopenia is a recognized independent risk factor associated with poor outcomes in cancer patients undergoing surgery. Patients with esophageal cancer are particularly susceptible to sarcopenia due to multiple factors. Purpose of the current study was to investigate the effect of sarcopenia on outcome and survival in patients undergoing full-robotic esophagectomy. This study includes all patients who underwent full-robotic abdominothoracic esophagectomy for esophageal cancer between January 2019 and December 2022. The skeletal muscle index, assessed by the preoperative computed tomographic staging scan, was used to classify the study cohort into a sarcopenic and a non-sarcopenic group. A total of 206 cases were included. With 168 patients (82%), prevalence of sarcopenia was high in the study population. The proportion of older (65.3 vs. 60.7\u00a0years, <jats:italic>p<\/jats:italic>\u2009=\u20090.0115), male (86% vs. 72%, <jats:italic>p<\/jats:italic>\u2009=\u20090.0469) and patients with tumor stenosis and\/or dysphagia after completion of neoadjuvant therapy (71% vs. 44%, <jats:italic>p<\/jats:italic>\u2009=\u20090.0035) in the sarcopenic group was significantly higher than in the non-sarcopenic group. Sarcopenia did not affect short-term outcomes including complication rates. However, overall- (17.4 vs. 22.8\u00a0months, <jats:italic>p<\/jats:italic>\u2009=\u20090.0458) and disease-free survival (15.3 vs. 22.6\u00a0months, <jats:italic>p<\/jats:italic>\u2009=\u20090.0069) was significantly reduced in sarcopenic patients. Preoperative sarcopenia was not associated with altered short-term outcomes but reduced overall- and disease-free survival. These findings underscore the critical need for prehabilitation and nutritional support for sarcopenic patients undergoing full-robotic esophagectomy, a complex procedure with inherently high morbidity.<\/jats:p>","DOI":"10.1038\/s41598-025-00058-7","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T17:57:31Z","timestamp":1746467851000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Sarcopenia worsens overall survival following robotic esophagectomy for esophageal cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Jennifer","family":"Merten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabila Gala","family":"Nacul Mora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Peter","family":"Hoelzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazen","family":"Juratli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Pascher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann-Kathrin","family":"Eichelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,5]]},"reference":[{"key":"58_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2021.106206","volume":"97","author":"P Wang","year":"2022","unstructured":"Wang, P. et al. Skeletal muscle wasting during neoadjuvant therapy as a prognosticator in patients with esophageal and esophagogastric junction cancer: A systematic review and meta-analysis. Int J Surg. 97, 106206. https:\/\/doi.org\/10.1016\/j.ijsu.2021.106206 (2022).","journal-title":"Int J Surg."},{"key":"58_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.892935","volume":"12","author":"XY Xu","year":"2022","unstructured":"Xu, X. Y. et al. Skeletal Muscle Change During Neoadjuvant Therapy and Its Impact on Prognosis in Patients With Gastrointestinal Cancers: A Systematic Review and Meta-Analysis. Front Oncol. 12, 892935. https:\/\/doi.org\/10.3389\/fonc.2022.892935 (2022).","journal-title":"Front Oncol."},{"key":"58_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-024-03304-w","author":"SL Li","year":"2024","unstructured":"Li, S. L. et al. Correlation between sarcopenia and esophageal cancer: A narrative review. World J. Surg. Oncol. https:\/\/doi.org\/10.1186\/s12957-024-03304-w (2024).","journal-title":"World J. Surg. Oncol."},{"issue":"5","key":"58_CR4","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1097\/SLA.0000000000002398","volume":"266","author":"JA Elliott","year":"2017","unstructured":"Elliott, J. A. et al. Sarcopenia: Prevalence, and impact on operative and oncologic outcomes in the multimodal management of locally advanced esophageal cancer. Ann. Surg. 266(5), 822\u2013830. https:\/\/doi.org\/10.1097\/SLA.0000000000002398 (2017).","journal-title":"Ann. Surg."},{"issue":"1","key":"58_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s13014-019-1372-3","volume":"14","author":"CM Panje","year":"2019","unstructured":"Panje, C. M. et al. Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75\/08 substudy. Radiat. Oncol. 14(1), 166. https:\/\/doi.org\/10.1186\/s13014-019-1372-3 (2019).","journal-title":"Radiat. Oncol."},{"issue":"12","key":"58_CR6","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.3390\/cancers13122921","volume":"13","author":"U Fehrenbach","year":"2021","unstructured":"Fehrenbach, U. et al. CT body composition of sarcopenia and sarcopenic obesity: Predictors of postoperative complications and survival in patients with locally advanced esophageal adenocarcinoma. Cancers 13(12), 2921 (2021).","journal-title":"Cancers"},{"issue":"1","key":"58_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jcsm.13126","volume":"14","author":"P Fang","year":"2023","unstructured":"Fang, P. et al. The prognostic value of sarcopenia in oesophageal cancer: A systematic review and meta-analysis. J. Cachexia Sarcopenia Muscle 14(1), 3\u201316. https:\/\/doi.org\/10.1002\/jcsm.13126 (2023).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"issue":"1","key":"58_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/nyas.13676","volume":"1434","author":"PP Grimminger","year":"2018","unstructured":"Grimminger, P. P. et al. Surgical robotics for esophageal cancer. Ann. Ny. Acad. Sci. 1434(1), 21\u201326. https:\/\/doi.org\/10.1111\/nyas.13676 (2018).","journal-title":"Ann. Ny. Acad. Sci."},{"issue":"5","key":"58_CR9","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1245\/s10434-021-11082-y","volume":"29","author":"SK Kamarajah","year":"2022","unstructured":"Kamarajah, S. K. et al. Robotic techniques in esophagogastric cancer surgery: An assessment of short- and long-term clinical outcomes. Ann. Surg. Oncol. 29(5), 2812\u20132825. https:\/\/doi.org\/10.1245\/s10434-021-11082-y (2022).","journal-title":"Ann. Surg. Oncol."},{"issue":"4","key":"58_CR10","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/SLA.0000000000003031","volume":"269","author":"PC van der Sluis","year":"2019","unstructured":"van der Sluis, P. C. et al. Robot-assisted minimally invasive thoracolaparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer: A randomized controlled trial. Ann. Surg. 269(4), 621\u2013630. https:\/\/doi.org\/10.1097\/SLA.0000000000003031 (2019).","journal-title":"Ann. Surg."},{"issue":"20","key":"58_CR11","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.3390\/cancers16203538","volume":"16","author":"I Budeyri","year":"2024","unstructured":"Budeyri, I. et al. Caseload per year in robotic-assisted minimally invasive esophagectomy: A narrative review. Cancers (Basel) 16(20), 3538. https:\/\/doi.org\/10.3390\/cancers16203538 (2024).","journal-title":"Cancers (Basel)"},{"issue":"3","key":"58_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/ueg2.12523","volume":"12","author":"R Porschen","year":"2024","unstructured":"Porschen, R. et al. Updated German guideline on diagnosis and treatment of squamous cell carcinoma and adenocarcinoma of the esophagus. United Eur. Gastroenterol. J. 12(3), 399\u2013411. https:\/\/doi.org\/10.1002\/ueg2.12523 (2024).","journal-title":"United Eur. Gastroenterol. J."},{"issue":"3","key":"58_CR13","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.surg.2024.05.023","volume":"176","author":"JP Hoelzen","year":"2024","unstructured":"Hoelzen, J. P. et al. Robotic-assisted esophagectomy with total mesoesophageal excision enhances R0-resection in patients with esophageal cancer: A single-center experience. Surgery 176(3), 721\u2013729. https:\/\/doi.org\/10.1016\/j.surg.2024.05.023 (2024).","journal-title":"Surgery"},{"issue":"7","key":"58_CR14","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","volume":"9","author":"CM Prado","year":"2008","unstructured":"Prado, C. M. et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study. Lancet Oncol. 9(7), 629\u2013635. https:\/\/doi.org\/10.1016\/S1470-2045(08)70153-0 (2008).","journal-title":"Lancet Oncol."},{"issue":"3","key":"58_CR15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1053\/j.gastro.2022.05.054","volume":"163","author":"E Morgan","year":"2022","unstructured":"Morgan, E. et al. The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: New estimates from GLOBOCAN. Gastroenterology 163(3), 649\u2013658. https:\/\/doi.org\/10.1053\/j.gastro.2022.05.054 (2022).","journal-title":"Gastroenterology"},{"issue":"1","key":"58_CR16","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12893-023-02149-6","volume":"23","author":"A Park","year":"2023","unstructured":"Park, A., Orlandini, M. F., Szor, D. J., Junior, U. R. & Tustumi, F. The impact of sarcopenia on esophagectomy for cancer: A systematic review and meta-analysis. BMC Surg. 23(1), 240. https:\/\/doi.org\/10.1186\/s12893-023-02149-6 (2023).","journal-title":"BMC Surg."},{"issue":"8","key":"58_CR17","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1245\/s10434-020-08236-9","volume":"27","author":"PY Wang","year":"2020","unstructured":"Wang, P. Y. et al. Sarcopenia and short-term outcomes after esophagectomy: A meta-analysis. Ann. Surg. Oncol. 27(8), 3041\u20133051. https:\/\/doi.org\/10.1245\/s10434-020-08236-9 (2020).","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"58_CR18","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/jcsm.12831","volume":"12","author":"J McGovern","year":"2021","unstructured":"McGovern, J., Dolan, R. D., Horgan, P. G., Laird, B. J. & McMillan, D. C. Computed tomography-defined low skeletal muscle index and density in cancer patients: Observations from a systematic review. J. Cachexia Sarcopenia Muscle 12(6), 1408\u20131417. https:\/\/doi.org\/10.1002\/jcsm.12831 (2021).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"issue":"8","key":"58_CR19","doi-asserted-by":"publisher","first-page":"doy047","DOI":"10.1093\/dote\/doy047","volume":"31","author":"PR Boshier","year":"2018","unstructured":"Boshier, P. R., Heneghan, R., Markar, S. R., Baracos, V. E. & Low, D. E. Assessment of body composition and sarcopenia in patients with esophageal cancer: A systematic review and meta-analysis. Dis. Esophagus 31(8), doy047. https:\/\/doi.org\/10.1093\/dote\/doy047 (2018).","journal-title":"Dis. Esophagus"},{"issue":"10191","key":"58_CR20","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/S0140-6736(19)31138-9","volume":"393","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft, A. J. & Sayer, A. A. Sarcopenia. Lancet 393(10191), 2636\u20132646. https:\/\/doi.org\/10.1016\/S0140-6736(19)31138-9 (2019).","journal-title":"Lancet"},{"issue":"1","key":"58_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/jcsm.12783","volume":"13","author":"F Petermann-Rocha","year":"2022","unstructured":"Petermann-Rocha, F. et al. Global prevalence of sarcopenia and severe sarcopenia: A systematic review and meta-analysis. J. Cachexia Sarcopeni. 13(1), 86\u201399. https:\/\/doi.org\/10.1002\/jcsm.12783 (2022).","journal-title":"J. Cachexia Sarcopeni."},{"issue":"9","key":"58_CR22","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.3390\/jcm13092520","volume":"13","author":"B Pedauye-Rueda","year":"2024","unstructured":"Pedauye-Rueda, B., Garcia-Fernandez, P., Maicas-Perez, L., Mate-Munoz, J. L. & Hernandez-Lougedo, J. Different diagnostic criteria for determining the prevalence of sarcopenia in older adults: A systematic review. J. Clin. Med. 13(9), 2520. https:\/\/doi.org\/10.3390\/jcm13092520 (2024).","journal-title":"J. Clin. Med."},{"issue":"12","key":"58_CR23","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1097\/JS9.0000000000000688","volume":"109","author":"S Knoedler","year":"2023","unstructured":"Knoedler, S. et al. Impact of sarcopenia on outcomes in surgical patients: A systematic review and meta-analysis. Int. J. Surg. 109(12), 4238\u20134262. https:\/\/doi.org\/10.1097\/JS9.0000000000000688 (2023).","journal-title":"Int. J. Surg."},{"key":"58_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/dote\/doac094","author":"EM de Groot","year":"2023","unstructured":"de Groot, E. M. et al. Management of anastomotic leakage after robot-assisted minimally invasive esophagectomy with an intrathoracic anastomosis. Dis. Esophagus https:\/\/doi.org\/10.1093\/dote\/doac094 (2023).","journal-title":"Dis. Esophagus"},{"issue":"5","key":"58_CR25","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/SLA.0000000000005125","volume":"274","author":"PC Muller","year":"2021","unstructured":"Muller, P. C. et al. Preemptive endoluminal vacuum therapy to reduce morbidity after minimally invasive Ivor Lewis Esophagectomy: Including a novel grading system for postoperative endoscopic assessment of GI-anastomoses. Ann. Surg. 274(5), 751\u2013757. https:\/\/doi.org\/10.1097\/SLA.0000000000005125 (2021).","journal-title":"Ann. Surg."},{"issue":"10","key":"58_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.108533","volume":"50","author":"C Mann","year":"2024","unstructured":"Mann, C. et al. Low psoas muscle index has a negative impact on survival after minimal invasive esophagectomy for cancer in European men. Eur. J. Surg. Oncol. 50(10), 108533. https:\/\/doi.org\/10.1016\/j.ejso.2024.108533 (2024).","journal-title":"Eur. J. Surg. Oncol."},{"issue":"4","key":"58_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5090\/kjtcs.2020.53.4.191","volume":"53","author":"YH Yang","year":"2020","unstructured":"Yang, Y. H., Park, S. Y. & Kim, D. J. Chyle leakage after esophageal cancer surgery. Korean J. Thorac. Cardiovasc. Surg. 53(4), 191\u2013199. https:\/\/doi.org\/10.5090\/kjtcs.2020.53.4.191 (2020).","journal-title":"Korean J. Thorac. Cardiovasc. Surg."},{"issue":"2","key":"58_CR28","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.athoracsur.2017.01.117","volume":"104","author":"TJ Weijs","year":"2017","unstructured":"Weijs, T. J., Ruurda, J. P., Broekhuizen, M. E., Bracco Gartner, T. C. L. & van Hillegersberg, R. Outcome of a step-up treatment strategy for chyle leakage after esophagectomy. Ann. Thorac. Surg. 104(2), 477\u2013484. https:\/\/doi.org\/10.1016\/j.athoracsur.2017.01.117 (2017).","journal-title":"Ann. Thorac. Surg."},{"issue":"4","key":"58_CR29","doi-asserted-by":"publisher","first-page":"877","DOI":"10.21037\/jtd-21-1580","volume":"14","author":"JM Halle-Smith","year":"2022","unstructured":"Halle-Smith, J. M., Siddaiah-Subramanya, M., Ghoneim, A., Almonib, A. & Tan, B. H. L. Influence of body composition measures on chyle leak after oesophagectomy. J. Thorac. Dis. 14(4), 877\u2013883. https:\/\/doi.org\/10.21037\/jtd-21-1580 (2022).","journal-title":"J. Thorac. Dis."},{"issue":"3","key":"58_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/dote\/doy115","volume":"32","author":"HY Deng","year":"2019","unstructured":"Deng, H. Y. et al. Preoperative sarcopenia is a predictor of poor prognosis of esophageal cancer after esophagectomy: A comprehensive systematic review and meta-analysis. Dis. Esophagus 32(3), 115 (2019).","journal-title":"Dis. Esophagus"},{"issue":"9","key":"58_CR31","doi-asserted-by":"publisher","first-page":"doab100","DOI":"10.1093\/dote\/doab100","volume":"35","author":"F Chen","year":"2022","unstructured":"Chen, F. et al. Impact of preoperative sarcopenia on postoperative complications and survival outcomes of patients with esophageal cancer: A meta-analysis of cohort studies. Dis. Esophagus 35(9), doab100. https:\/\/doi.org\/10.1093\/dote\/doab100 (2022).","journal-title":"Dis. Esophagus"},{"issue":"6","key":"58_CR32","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s12094-016-1593-y","volume":"19","author":"V Bar-Ad","year":"2017","unstructured":"Bar-Ad, V. et al. Neutrophil to lymphocyte ratio associated with prognosis of lung cancer. Clin. Transl. Oncol. 19(6), 711\u2013717. https:\/\/doi.org\/10.1007\/s12094-016-1593-y (2017).","journal-title":"Clin. Transl. Oncol."},{"issue":"3","key":"58_CR33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5761\/atcs.oa.17-00215","volume":"24","author":"T Tsukioka","year":"2018","unstructured":"Tsukioka, T. et al. Loss of muscle mass is a novel predictor of postoperative early recurrence in N2-positive non-small-cell lung cancer. Ann. Thorac. Cardiovasc. Surg. 24(3), 121\u2013126. https:\/\/doi.org\/10.5761\/atcs.oa.17-00215 (2018).","journal-title":"Ann. Thorac. Cardiovasc. Surg."},{"issue":"1","key":"58_CR34","doi-asserted-by":"publisher","first-page":"449","DOI":"10.21873\/anticanres.13133","volume":"39","author":"T Matsunaga","year":"2019","unstructured":"Matsunaga, T. et al. Prognostic significance of sarcopenia and systemic inflammatory response in patients with esophageal cancer. Anticancer Res. 39(1), 449\u2013458. https:\/\/doi.org\/10.21873\/anticanres.13133 (2019).","journal-title":"Anticancer Res."},{"key":"58_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx815","author":"R Dev","year":"2018","unstructured":"Dev, R., Bruera, E. & Dalal, S. Insulin resistance and body composition in cancer patients. Ann. Oncol. https:\/\/doi.org\/10.1093\/annonc\/mdx815 (2018).","journal-title":"Ann. Oncol."},{"issue":"3","key":"58_CR36","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ejso.2014.11.040","volume":"41","author":"BHL Tan","year":"2015","unstructured":"Tan, B. H. L. et al. Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer. Ejso-Eur. J. Surg. Onc. 41(3), 333\u2013338. https:\/\/doi.org\/10.1016\/j.ejso.2014.11.040 (2015).","journal-title":"Ejso-Eur. J. Surg. Onc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00058-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00058-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00058-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T17:57:32Z","timestamp":1746467852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-00058-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["58"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-00058-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,5]]},"assertion":[{"value":"21 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jens P. H\u00f6lzen is a proctor for Intuitive Surgical, Inc (Sunnyvale, CA). All authors declare they have no competing interests that may be relevant to the contents of this article. We have not received any financial or material support.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the institutional research committee (Ethikkommission Westfalen-Lippe, 2018-137-f-S).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"15726"}}